;PMID: 10715586
;source_file_2882.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..49] = [t:0..49]
;1)sentence:[e:55..130] = [t:55..130]
;2)section:[e:134..188] = [t:134..188]
;3)section:[e:192..339] = [t:192..339]
;4)sentence:[e:343..549] = [t:343..549]
;5)sentence:[e:550..726] = [t:550..726]
;6)sentence:[e:727..815] = [t:727..815]
;7)sentence:[e:816..1097] = [t:816..1097]
;8)sentence:[e:1098..1365] = [t:1098..1365]
;9)section:[e:1369..1414] = [t:1369..1414]

;section 0 Span:0..49
;Int J Dev Neurosci.  2000 Apr-Jun;18(2-3):317-20.
(SEC
  (FRAG (NNP:[0..3] Int) (NNP:[4..5] J) (NNP:[6..9] Dev) (NNP:[10..18] Neurosci)
        (.:[18..19] .) (CD:[21..25] 2000) (NNP:[26..29] Apr) (HYPH:[29..30] -)
        (CD:[30..36] Jun;18) (-LRB-:[36..37] -LRB-) (NN:[37..40] 2-3)
        (-RRB-:[40..41] -RRB-) (CD:[41..46] :317-) (CD:[46..48] 20)
        (.:[48..49] .)))

;sentence 1 Span:55..130
;Expression of the estrogen-regulated gene Nip2 during rat brain maturation.
;[97..101]:gene-rna:"Nip2"
(SENT
  (NP-HLN
    (NP (NN:[55..65] Expression))
    (PP (IN:[66..68] of)
      (NP
        (NP (DT:[69..72] the)
          (ADJP (NN:[73..81] estrogen) (HYPH:[81..82] -)
                (VBN:[82..91] regulated))
          (NN:[92..96] gene))
        (NP (NN:[97..101] Nip2))))
    (PP-TMP (IN:[102..108] during)
      (NP
        (NML (NN:[109..112] rat) (NN:[113..118] brain))
        (NN:[119..129] maturation)))
    (.:[129..130] .)))

;section 2 Span:134..188
;Brusadelli A, Sialino H, Piepoli T, Pollio G, Maggi A.
(SEC
  (FRAG (NNP:[134..144] Brusadelli) (NNP:[145..146] A) (,:[146..147] ,)
        (NNP:[148..155] Sialino) (NNP:[156..158] H,) (NNP:[159..166] Piepoli)
        (NNP:[167..168] T) (,:[168..169] ,) (NNP:[170..176] Pollio)
        (NNP:[177..178] G) (,:[178..179] ,) (NNP:[180..185] Maggi)
        (NNP:[186..187] A) (.:[187..188] .)))

;section 3 Span:192..339
;Center Milano Molecular Pharmacology Laboratory, Institute of Pharmacological
; Sciences, University of Milan, Via Balzaretti 9 20133, Milan, Italy.
(SEC
  (FRAG (NNP:[192..198] Center) (NNP:[199..205] Milano)
        (NNP:[206..215] Molecular) (NNP:[216..228] Pharmacology)
        (NNP:[229..239] Laboratory) (,:[239..240] ,) (NNP:[241..250] Institute)
        (IN:[251..253] of) (NNP:[254..269] Pharmacological)
        (NNP:[271..279] Sciences) (,:[279..280] ,) (NNP:[281..291] University)
        (IN:[292..294] of) (NNP:[295..300] Milan) (,:[300..301] ,)
        (NNP:[302..305] Via) (NNP:[306..316] Balzaretti) (CD:[317..318] 9)
        (CD:[319..324] 20133) (,:[324..325] ,) (NNP:[326..331] Milan)
        (,:[331..332] ,) (NNP:[333..338] Italy) (.:[338..339] .)))

;sentence 4 Span:343..549
;The present study stems from previous observations demonstrating that in the 
;neuroblastoma cell line SK-ER3 the mRNA content of the pro-apoptotic gene
;Nip2  is decreased following treatment with estradiol.
;[421..434]:malignancy-type:"neuroblastoma"
;[495..499]:gene-rna:"Nip2"
(SENT
  (S
    (NP-SBJ (DT:[343..346] The) (JJ:[347..354] present) (NN:[355..360] study))
    (VP (VBZ:[361..366] stems)
      (PP (IN:[367..371] from)
        (NP
          (NP (JJ:[372..380] previous) (NNS:[381..393] observations))
          (VP (VBG:[394..407] demonstrating)
            (SBAR (IN:[408..412] that)
              (S
                (PP (IN:[413..415] in)
                  (NP
                    (NP (DT:[416..419] the) (NN:[421..434] neuroblastoma)
                        (NN:[435..439] cell) (NN:[440..444] line))
                    (NP (NN:[445..451] SK-ER3))))
                (NP-SBJ-1
                  (NP (DT:[452..455] the) (NN:[456..460] mRNA)
                      (NN:[461..468] content))
                  (PP (IN:[469..471] of)
                    (NP
                      (NP (DT:[472..475] the)
                        (ADJP (AFX:[476..479] pro) (HYPH:[479..480] -)
                              (JJ:[480..489] apoptotic))
                        (NN:[490..494] gene))
                      (NP (NN:[495..499] Nip2)))))
                (VP (VBZ:[501..503] is)
                  (VP (VBN:[504..513] decreased)
                    (NP-1 (-NONE-:[513..513] *))
                    (PP-TMP (VBG:[514..523] following)
                      (NP
                        (NP (NN:[524..533] treatment))
                        (PP (IN:[534..538] with)
                          (NP (NN:[539..548] estradiol)))))))))))))
    (.:[548..549] .)))

;sentence 5 Span:550..726
;We investigate the content of  Nip2 mRNA during the maturation of rat embryo
;brain and we show that Nip2 mRNA  is very low at embryo day 15 and steadily
;increases up to day 20.
;[581..585]:gene-rna:"Nip2"
;[650..654]:gene-rna:"Nip2"
(SENT
  (S
    (NP-SBJ (PRP:[550..552] We))
    (VP (VBP:[553..564] investigate)
      (NP
        (NP (DT:[565..568] the) (NN:[569..576] content))
        (PP (IN:[577..579] of)
          (NP (NN:[581..585] Nip2) (NN:[586..590] mRNA)))
        (PP-TMP (IN:[591..597] during)
          (NP
            (NP (DT:[598..601] the) (NN:[602..612] maturation))
            (PP (IN:[613..615] of)
              (NP (NN:[616..619] rat) (NN:[620..626] embryo)
                  (NN:[627..632] brain)))))))
    (CC:[633..636] and)
    (S
      (NP-SBJ (PRP:[637..639] we))
      (VP (VBP:[640..644] show)
        (SBAR (IN:[645..649] that)
          (S
            (NP-SBJ (NN:[650..654] Nip2) (NN:[655..659] mRNA))
            (VP
              (VP (VBZ:[661..663] is)
                (ADJP-PRD (RB:[664..668] very) (JJ:[669..672] low))
                (PP-TMP (IN:[673..675] at)
                  (NP (NN:[676..682] embryo) (NN:[683..686] day)
                      (CD:[687..689] 15))))
              (CC:[690..693] and)
              (VP
                (ADVP (RB:[694..702] steadily))
                (VBZ:[703..712] increases)
                (PP (IN:[713..715] up)
                  (PP (TO:[716..718] to)
                    (NP (NN:[719..722] day) (CD:[723..725] 20))))))))))
    (.:[725..726] .)))

;sentence 6 Span:727..815
;At day 21 Nip2  mRNA is decreased almost to the low levels observed in the
;mature brain.
;[737..741]:gene-rna:"Nip2"
(SENT
  (S
    (PP-TMP (IN:[727..729] At)
      (NP (NN:[730..733] day) (CD:[734..736] 21)))
    (NP-SBJ-1 (NN:[737..741] Nip2) (NN:[743..747] mRNA))
    (VP (VBZ:[748..750] is)
      (VP (VBN:[751..760] decreased)
        (NP-1 (-NONE-:[760..760] *))
        (PP
          (ADVP (RB:[761..767] almost))
          (TO:[768..770] to)
          (NP
            (NP (DT:[771..774] the) (JJ:[775..778] low) (NNS:[779..785] levels))
            (VP (VBN:[786..794] observed)
              (NP (-NONE-:[794..794] *))
              (PP-LOC (IN:[795..797] in)
                (NP (DT:[798..801] the) (JJ:[802..808] mature)
                    (NN:[809..814] brain))))))))
    (.:[814..815] .)))

;sentence 7 Span:816..1097
;Studies  in neurons from rat embryo at day 18 show that Nip2 mRNA content is 
;significantly decreased by exposure to estradiol at 1 nM concentration 
;demonstrating that the observations previously done in the SK-ER3
;neuroblastoma  cell line can be reproduced in neurons in culture.
;[872..876]:gene-rna:"Nip2"
;[1032..1045]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ
      (NP (NNS:[816..823] Studies))
      (PP (IN:[825..827] in)
        (NP
          (NP (NNS:[828..835] neurons))
          (PP (IN:[836..840] from)
            (NP
              (NP (NN:[841..844] rat) (NN:[845..851] embryo))
              (PP-TMP (IN:[852..854] at)
                (NP (NN:[855..858] day) (CD:[859..861] 18))))))))
    (VP (VBP:[862..866] show)
      (SBAR (IN:[867..871] that)
        (S
          (NP-SBJ-1 (NN:[872..876] Nip2) (NN:[877..881] mRNA)
                    (NN:[882..889] content))
          (VP (VBZ:[890..892] is)
            (VP
              (ADVP (RB:[894..907] significantly))
              (VBN:[908..917] decreased)
              (NP-1 (-NONE-:[917..917] *))
              (PP (IN:[918..920] by)
                (NP-LGS
                  (NP (NN:[921..929] exposure))
                  (PP (TO:[930..932] to)
                    (NP (NN:[933..942] estradiol)))
                  (PP (IN:[943..945] at)
                    (NP
                      (NML (CD:[946..947] 1) (NN:[948..950] nM))
                      (NN:[951..964] concentration)))))
              (S-ADV
                (NP-SBJ (-NONE-:[964..964] *))
                (VP (VBG:[966..979] demonstrating)
                  (SBAR (IN:[980..984] that)
                    (S
                      (NP-SBJ-2
                        (NP (DT:[985..988] the) (NNS:[989..1001] observations))
                        (VP
                          (ADVP-TMP (RB:[1002..1012] previously))
                          (VBN:[1013..1017] done)
                          (NP (-NONE-:[1017..1017] *))
                          (PP (IN:[1018..1020] in)
                            (NP (DT:[1021..1024] the) (NN:[1025..1031] SK-ER3)
                                (NN:[1032..1045] neuroblastoma)
                                (NN:[1047..1051] cell) (NN:[1052..1056] line)))))
                      (VP (MD:[1057..1060] can)
                        (VP (VB:[1061..1063] be)
                          (VP (VBN:[1064..1074] reproduced)
                            (NP-2 (-NONE-:[1074..1074] *))
                            (PP (IN:[1075..1077] in)
                              (NP
                                (NP (NNS:[1078..1085] neurons))
                                (PP (IN:[1086..1088] in)
                                  (NP (NN:[1089..1096] culture)))))))))))))))))
    (.:[1096..1097] .)))

;sentence 8 Span:1098..1365
;The finding that estrogens  may modulate the activity of Nip2 gene activity
;may be of relevance not only  with regard to the effects of estradiol on
;brain maturation, but also for the  understanding of the neuroprotective
;effects recently described for this  hormone.
;[1155..1159]:gene-rna:"Nip2"
(SENT
  (S
    (NP-SBJ (DT:[1098..1101] The) (NN:[1102..1109] finding)
      (SBAR (IN:[1110..1114] that)
        (S
          (NP-SBJ (NNS:[1115..1124] estrogens))
          (VP (MD:[1126..1129] may)
            (VP (VB:[1130..1138] modulate)
              (NP
                (NP (DT:[1139..1142] the) (NN:[1143..1151] activity))
                (PP (IN:[1152..1154] of)
                  (NP (NN:[1155..1159] Nip2) (NN:[1160..1164] gene)
                      (NN:[1165..1173] activity)))))))))
    (VP (MD:[1174..1177] may)
      (VP (VB:[1178..1180] be)
        (PP-PRD (IN:[1181..1183] of)
          (NP
            (NP (NN:[1184..1193] relevance))
            (PP
              (CONJP (RB:[1194..1197] not) (RB:[1198..1202] only))
              (PP (IN:[1204..1208] with)
                (NP
                  (NP (NN:[1209..1215] regard))
                  (PP (TO:[1216..1218] to)
                    (NP
                      (NP (DT:[1219..1222] the) (NNS:[1223..1230] effects))
                      (PP (IN:[1231..1233] of)
                        (NP (NN:[1234..1243] estradiol)))
                      (PP (IN:[1244..1246] on)
                        (NP (NN:[1247..1252] brain) (NN:[1253..1263] maturation)))))))
              (,:[1263..1264] ,)
              (CONJP (CC:[1265..1268] but) (RB:[1269..1273] also))
              (PP (IN:[1274..1277] for)
                (NP
                  (NP (DT:[1278..1281] the) (NN:[1283..1296] understanding))
                  (PP (IN:[1297..1299] of)
                    (NP
                      (NP (DT:[1300..1303] the)
                          (JJ:[1304..1319] neuroprotective)
                          (NNS:[1320..1327] effects))
                      (VP
                        (ADVP (RB:[1328..1336] recently))
                        (VBN:[1337..1346] described)
                        (PP (IN:[1347..1350] for)
                          (NP (DT:[1351..1355] this) (NN:[1357..1364] hormone)))))))))))))
    (.:[1364..1365] .)))

;section 9 Span:1369..1414
;PMID: 10715586 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1369..1373] PMID) (::[1373..1374] :) (CD:[1375..1383] 10715586)
        (NN:[1384..1385] -LSB-) (NNP:[1385..1391] PubMed) (::[1392..1393] -)
        (NN:[1394..1401] indexed) (IN:[1402..1405] for)
        (NNP:[1406..1414] MEDLINE-RSB-)))
